MiMedx Group Inc (NAS:MDXG)
$ 6.13 -0.1 (-1.61%) Market Cap: 899.94 Mil Enterprise Value: 850.15 Mil PE Ratio: 9.81 PB Ratio: 5.35 GF Score: 76/100

Q3 2022 MiMedx Group Inc Earnings Call Transcript

Nov 02, 2022 / 09:00PM GMT
Release Date Price: $2.76 (-8.61%)
Operator

Good afternoon and thank you for standing by. Welcome to the MiMedx Third Quarter 2022 Operating and Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host today, Mr. Matt Notarianni, Head of Investor Relations for MiMedx. Thank you. You may begin.

Matthew M. Notarianni
MiMedx Group, Inc. - Head of IR

Thank you, Latonya, and good afternoon everyone. Welcome to the MiMedx third quarter 2022 operating and financial results conference call.

With me on today's call are Interim Chief Executive Officer, Todd Newton; Chief Financial Officer, Pete Carlson; President, Wound and Surgical, Dr. Rohit Kashyap; and President, Regenerative Medicine, Dr. Robert Stein. As part of today's webcast, we are simultaneously displaying slides that you can follow. You can access the slides from the Investor Relations website at mimedx.com. Todd and Pete will provide a summary of our operating highlights and financial results for the quarter and Todd will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot